Exact Sciences Corp - Company Profile
Powered by 
All the sales intelligence you need on Exact Sciences Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Exact Sciences Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Exact Sciences Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Exact Sciences Corp (Exact Sciences), a subsidiary of Abbott Laboratories, is a molecular diagnostic company that focuses on the development of tests for various types of cancers. The company develops and delivers solutions for cancer detection and treatment guidance. Its major products include the Cologuard test, Oncotype DX tests, and a non-invasive colorectal cancer screening test, which provide genomic insights for cancer treatment. The company operates through a network of healthcare providers and partners to distribute its products. Exact Sciences is headquartered in Madison, Wisconsin, the US.
Headquarters
United States of America
Address
5505 Endeavor Lane, Madison, Wisconsin, 53719
Website
www.exactsciences.com
Telephone
1 608 2845700
No of Employees
7,200
Industry
Medical Equipment
Revenue (2025)
$3.2B
Exact Sciences Corp premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Cologuard Test - Non-Invasive Stool-Based DNA (sDNA) Screening Test | Cologuard |
| Oncotype DX Gene Expression Tests - for Breast, Prostate and Colon Cancers | LBgard |
| Oncotype DX AR-V7 Nucleus Detect Test - for Advanced Stage Prostate Cancer | Oncodetect |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Ownership Changes | In March, the company was acquired by Abbott Laboratories, a medical devices and healthcare company. |
| 2026 | Regulatory Approval | In February, the company received approval from its shareholders to sell its entire stake to Abbott Laboratories, a healthcare company. |
| 2025 | Contracts/Agreements | In September, the company and Healthmine partnered to enhance colorectal cancer screening rates through improved member engagement and rewards. |
Competitor Comparison
| Key Parameters | Exact Sciences Corp | Siemens AG | Roche Holding AG | Labcorp Holdings Inc | Quest Diagnostics Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | Germany | Switzerland | United States of America | United States of America |
| City | Madison | Munich | Basel | Burlington | Secaucus |
| State/Province | Wisconsin | - | Basel-Stadt | North Carolina | New Jersey |
| No. of Employees | 7,200 | 317,000 | 112,774 | 71,000 | 46,000 |
| Entity Type | Private | Public | Public | Public | Public |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Kevin T. Conroy | Chairman; President; Chief Executive Officer | Executive Board | 2014 | 59 |
| Aaron Bloomer | Chief Financial Officer; Executive Vice President | Senior Management | 2024 | 39 |
| Brian Baranick | General Manager - Precision Oncology; Executive Vice President | Senior Management | 2022 | 47 |
| James Herriott | Secretary; General Counsel; Senior Vice President | Senior Management | 2022 | 45 |
| Jake Orville | Executive Vice President; General Manager - Screening | Senior Management | 2022 | 51 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer